openPR Logo

Press Releases from P&S Market Research - Pharmaceuticals (132 total)

Anal Cancer Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Pa …

Anal cancer therapeutic pipeline analysis is expected to increase owing to increasing incidence globally, majorly in older adults. Major factors driving towards the pipeline growth

Neuroblastoma Therapeutics Pipeline Analysis, 2017 - Patent, Designation, Collab …

The neuroblastoma therapeutics pipeline is expected to witness considerable growth in the future due to high prevalence of tumour in children. According to the American

Myocardial Infarction Therapeutics Pipeline Analysis, 2017

The myocardial infarction therapeutics pipeline is expected to increase in future due to rise in prevalence of myocardial infarction. Myocardial infarction is also commonly known

Hemophilia Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Pat …

The hemophilia therapeutics pipeline is expected to grow in future due to rise in prevalence of genetic variation. Hemophilia which is symptomatized by excessive bleeding

Pulmonary Arterial Hypertension Therapeutics Pipeline Analysis, 2017 - Clinical …

The pulmonary arterial hypertension therapeutics pipeline is expected to increase in over next few years due to increasing prevalence of pulmonary arterial hypertension. Pulmonary arterial

Growth Hormone Deficiency Therapeutics Pipeline Analysis, 2017 - Clinical Trials …

Growth hormone deficiency (GHD) therapeutics pipeline is predicted to increase in future mainly due to the increasing prevalence of the disease, globally. The major factors

Diabetic Retinopathy Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Re …

Diabetic retinopathy therapeutic pipeline analysis is projected to grow as perceived by the current situation of increasing prevalence of diabetes, globally. Some of the main

Diabetic Gastroparesis Therapeutics Pipeline Analysis, 2017 by P&S Market Resear …

Diabetic Gastroparesis therapeutic pipeline analysis is expected to grow as observed by the current situation of increasing prevalence of diabetes, globally. Major factors driving the

Bipolar Disorder Therapeutics Pipeline Analysis, 2017 - Designation, Collaborati …

Bipolar disorder therapeutic pipeline analysis is expected to increase on account of increasing instances of issues related to depression and other mental disorders, across the

Atopic Dermatitis Pipeline Analysis, 2017 - P&S Market Research

The pipeline for atopic dermatitis therapeutic is expected to witness significant growth in the future due to rising prevalence of the disease and food allergies,

Venous Thromboembolism Therapeutics Pipeline Analysis, 2017 - Clinical Trials & …

The venous thromboembolism therapeutics pipeline is expected to witness considerable growth in the coming year due to the development of novel oral anticoagulants as a

Kaposi sarcoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, …

The kaposi sarcoma therapeutics pipeline is expected to grow rapidly as the disease also has the risk of the patient being infected with Acquired Immune

Gallbladder Cancer Therapeutics Pipeline Analysis, 2017 by P&S Market Research

Gallbladder cancer therapeutics pipeline is expected to witness increased growth in the future since very less number of drugs are available in the pipeline for

Fallopian Tube Cancer Therapeutics Pipeline Analysis, 2017 by P&S Market Researc …

The fallopian tube cancer therapeutics pipeline is a major focus for the pharmaceutical companies and researchers since it is one of the most debilitating women’s

Cytomegalovirus (CMV) Infection Therapeutics Pipeline Analysis, 2017 by P&S Mark …

The rising number of the research and development activities for the pipeline drugs acts as drivers for the cytomegalovirus infection therapeutics pipeline. The prophylaxis treatment

Crohn’s Disease Therapeutics Pipeline Analysis, 2017 by P&S Market Research

The Crohn’s disease therapeutics pipeline is expected to witness extensive growth in the coming year due to emerging biosimilars and novel treatments. In addition, increasing

Acute Respiratory Distress Syndrome Therapeutics Pipeline Analysis, 2017 by P&S …

The acute respiratory distress syndrome therapeutics pipeline is expected to witness nominal growth in the coming year due to the slow research and development activities

Thyroid Cancer Therapeutics Pipeline Analysis, 2017 by P&S Market Research

The thyroid cancer therapeutics pipeline is expected to witness considerable growth due to increase in the demand for the targeted drug formulation for the treatment

Multiple Myeloma (MM) Therapeutics Pipeline Analysis, 2017 by P&S Market Researc …

The multiple myeloma therapeutics pipeline is expected to witness considerable growth in the coming year due to high prevalence of the disease. The growth of

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors Pipeline Analysis, 2017 by P&S M …

The PI3K inhibitors pipeline analysis report covers approximately 37 active drug candidates, of which eight drug candidates are in Phase III stage, 10 drug candidates

Novel Targets for Treatment of Various Diseases Push Pipeline Growth

The PI3K inhibitors pipeline analysis report covers approximately 37 active drug candidates, of which eight drug candidates are in Phase III stage, 10 drug candidates

Global Testicular Cancer Therapeutics Market - Epidemiology Analysis, Therapy, D …

Global testicular cancer therapeutics market is growing with the increasing prevalence of testicular cancer. The market is expected to witness moderate growth, since there are

Alzheimer’s Disease Pipeline Analysis, 2017 by P&S Market Research

The study analyzed that the Alzheimer's disease pipeline comprises 89 drug candidates, of which 17 products are in Phase III, 28 products are in Phase

Sjögren’s Syndrome Therapeutics Pipeline Analysis, 2017

The study analyzed that Sjögren’s syndrome pipeline comprises of approximately 42 drug candidates, of which 29 drug candidates are in active stage. Among the active

IgA Nephropathy Exhibits Emerging Pipeline with 11+ Drug Candidates

The study analyzed that the IgA nephropathy pipeline comprises of 12 drug candidates, of which one drug candidate is in Phase III stage, five drug

Bile Duct Cancer Therapeutics Market Epidemiology Analysis, Therapy, Development …

The global bile duct cancer therapeutics market is expected to witness noticeable growth, in the near future, owing to increasing awareness about cancer and advancements

Oropharyngeal Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Growt …

The global oropharyngeal cancer therapeutics market is expected to have significant growth since the pipeline for oropharyngeal cancer is growing rapidly. Also, there are no

Neuroendocrine Carcinoma Therapeutics Market - Epidemiology Analysis, Developmen …

Global neuroendocrine carcinoma therapeutics market is witnessing significant growth due to large number of marketed drugs and Phase III drugs. Neuroendocrine carcinoma is a tumor

Endometrial Cancer Therapeutics Market Analysis, Development, Growth and Demand …

Global endometrial cancer therapeutics market is expected to witness significant growth as there are less number of approved drugs for treatment of endometrial cancer, leading

Acute Lymphoblastic Leukemia (ALL) Therapeutics Market - Epidemiology Analysis, …

The global acute lymphoblastic leukemia therapeutics market is expected to witness considerable growth in the coming year since new drug formulations are proving to be

Acute Myeloid Leukemia (AML) Therapeutics Market - Epidemiology Analysis, Therap …

The global acute myeloid leukemia therapeutics market is expected to witness notable growth, in the coming year due to increase in the new innovative and

Chronic Lymphocytic Leukemia (CLL) Therapeutics Market Chronic Lymphocytic Leuke …

The global chronic lymphocytic leukemia therapeutics market is expected to create more opportunities in oncology due to promising pipeline and positive clinical data of drug

Go To Page:    1 2